No Picture
News

Method to derive blood vessel cells from skin cells suggests ways to slow aging

LA JOLLA—Salk scientists have used skin cells called fibroblasts from young and old patients to successfully create blood vessels cells that retain their molecular markers of age. The team’s approach, described in the journal eLife on September 8, 2020, revealed clues as to why blood vessels tend to become leaky… Click here to view original post… […]

No Picture
News

San Diego Nathan Shock Center announces pilot grant awardees

LA JOLLA—The San Diego Nathan Shock Center (SD-NSC) of Excellence in the Basic Biology of Aging, a consortium between the Salk Institute for Biological Studies, Sanford Burnham Prebys (SBP) and the University of California San Diego, has announced its second-year class of pilot grant awardees. Recipients from six different… Click here to view original post… […]

No Picture
News

UC San Diego Breaks Ground on Revitalization of Hillcrest Campus

A celebratory groundbreaking event marks the beginning of a comprehensive revitalization project of UC San Diego’s Hillcrest campus, which upon completion will feature state-of-the-art facilities, expanded patient care services and technologies and other community amenities to promote wellbeing. Click here to view original post… […]

No Picture
News

Salk scientists receive the 2021 ASPIRE award to study pancreatic cancer

LA JOLLA—Professor Ronald Evans and Assistant Professor Dannielle Engle have been granted a 2021 ASPIRE (Accelerating Scientific Platforms and Innovative Research) award to study the cellular and molecular drivers of pancreatic cancer, one of the deadliest cancers with few effective treatment options. The $250,000 award, supported by the… Click here to view original post… […]

No Picture
News

Pain and anxiety impact breathing on a cellular level

LA JOLLA—You’re startled by a threatening sound, and your breath quickens; you smash your elbow and pant in pain. Why a person’s breathing rate increases dramatically when they’re hurting or anxious was not previously understood. Now, a team of Salk scientists has uncovered a neural network in the brain that… Click here to view original post… […]

No Picture
News

OncoSec Announces Changes to its Board of Directors

PENNINGTON, N.J. and SAN DIEGO: PENNINGTON, N.J. and SAN DIEGO, Dec. 17, 2021 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body’s immune system to target and attack cancer, today announced that Margaret Dalesandro,… Click here to view original post… […]

No Picture
News

ScienceMedia Becomes the Exclusive Partner for Worldwide Clinical Trials’ On-Demand Therapeutic Training Needs

SAN DIEGO and RESEARCH TRIANGLE PARK, N.C.: SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Dec. 17, 2021 /PRNewswire/ — ScienceMedia, the leader in protocol compliance management, has entered into a multi-year license agreement with Worldwide Clinical Trials ("Worldwide") for SMi Source, the largest mobile-enabled disease state and clinical educator. License… Click here to view original post… […]

No Picture
News

Sara Kenkare-Mitra leaves Genentech for a chance to lead neuro R&D; GlaxoSmithKline alum jumps to Vifor Pharma with the lid lifted on sale to CSL

Sara Kenkare-Mitra Sara Kenkare-Mitra spent more than 23 years at biotech behemoth Genentech, climbing the corporate ladder from small molecule scientist all the way up to SVP of developmental sciences. At the same time, she was an adjunct professor at her alma mater, UC San Francisco…. Click here to view original post… […]

No Picture
News

Histogen Announces $3.5 Million Private Placement

SAN DIEGO, Dec. 16, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, announced today that it has entered into securities purchase agreements with certain institutional and… Click here to view original post… […]

No Picture
News

Diabetes Research Connection Celebrates Achievements Amid Year-End Giving Campaign to Fund Type 1 Diabetes Research

SAN DIEGO–(BUSINESS WIRE)– #DRC–DRC announces significant achievements amid year-end giving campaign supported by $100,000 dollar-for-dollar matching gift from anonymous donor. Click here to view original post… […]

No Picture
News

Viracta Therapeutics to be Added to the Nasdaq Biotechnology Index

SAN DIEGO: SAN DIEGO, Dec. 16, 2021 /PRNewswire/ — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has been selected for addition to the Nasdaq Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 20, 2021. The NBI is… Click here to view original post… […]

No Picture
News

EPIC SCIENCES UNVEILS DefineMBC™, A NOVEL BLOOD-BASED TEST DESIGNED TO IMPROVE CARE FOR METASTATIC BREAST CANCER PATIENTS

SAN DIEGO: SAN DIEGO, Dec. 16, 2021 /PRNewswire/ — Epic Sciences, Inc. announces DefineMBC, a novel metastatic breast cancer (MBC) test that includes both cell-based and cell-free analysis from a single blood draw. DefineMBC provides comprehensive MBC profiling when a tissue biopsy result is not available. "Tissue biopsy to confirm… Click here to view original post… […]

No Picture
News

Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT Product Candidate to Include HIV Prevention

SAN DIEGO: SAN DIEGO, Dec. 16, 2021 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) and Orion Biotechnology Canada Ltd. today announced that they have entered into a collaboration agreement to evaluate the compatibility and stability of Orion’s novel CCR5 antagonist, OB-002, in Evofem’s Phexxi® (lactic acid, citric acid and potassium… Click here to view original post… […]